Oncoplastic level II volume displacement surgery for breast cancer: oncological and aesthetic outcomes - Summary - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Oncoplastic Level II Volume Displacement Surgery for Breast Cancer: Aesthetic and Oncological Results

  • By

  • Marco Sparavigna

  • Marco Gipponi

  • Luca Carmisciano

  • Simonetta Franchelli

  • Giulia Atzori

  • Chiara Cornacchia

  • Raquel Diaz

  • Federica Murelli

  • Francesca Depaoli

  • Daniele Friedman

  • Piero Fregatti

  • March 2, 2023

Share

Objective:

To assess the oncological safety and patient satisfaction of oncoplastic breast conserving surgery (OBCS) in breast cancer patients, highlighting the significance of these outcomes.

Key Findings:
  • Margin involvement occurred in 2.7% of cases, with a 5-year overall survival (OS) of 97% and disease-free survival (DFS) of 94%.
  • Post-operative complications were noted in 17% of patients, all managed conservatively.
  • The average patient satisfaction index measured by BREAST-Q was reported, indicating overall satisfaction with the surgical outcomes, with specific values included.
Interpretation:

The study suggests that OBCS provides favorable oncological outcomes and high patient satisfaction, supporting its use in breast cancer treatment and its implications for clinical practice.

Limitations:
  • The study is retrospective and may have selection bias.
  • The sample size is relatively small and may not be generalizable.
  • Patient satisfaction was assessed at varying times post-surgery, which could affect results, and potential biases in patient-reported outcomes should be considered.
Conclusion:

Oncoplastic level II volume displacement surgery demonstrates promising oncological safety and patient satisfaction, warranting further validation in larger studies to confirm these findings.

Original Source(s)

Related Content